RBRachana Bhat

Rachana Bhat

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Rachana Bhat has a total of 47 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Factors associated with severity in Klebsiella pneumoniae community-acquired pneumonia: A retrospective cohort study from South India

    by Souvik Chaudhuri, Tirlangi Praveen Kumar, Shreya Das Adhikari, Danavath Nagendra, Prithvishree Ravindra, Rachana Bhat, K.E. Vandana, Nitin Gupta

  • Pediatric Head and Maxillofacial Trauma

    by Manju Dhandapani, C. Vasantha Kalyani, Malar Kodi S, Asish Kishore, Rachana Bhat

  • Open Access

    Predicting severity in spotted fever in India: A retrospective cohort study

    by Nitin Gupta, Praveen Kumar Tirlangi, Rachana Bhat, S. Chaithra, Mohammad Arham Parvez, V. Shashidhar, Seema Shetty, Muralidhar Varma, K.E. Vandana, Prithvishree Ravindra

  • Open Access

    Role of biomarkers in predicting mortality in patients with flaviviral disease endemic to South India: a retrospective observational study

    by Nitin Gupta, Pothumarthy Venkata Swathi Kiran, Mohammad Khalid, Tirlangi Praveen Kumar, Prithvishree Ravindra, Rachana Bhat

    Background: Flaviviral infections such as dengue and Kyasanur Forest Disease (KFD) are endemic causes of acute febrile illness in South India, with some cases progressing to severe disease and death. Methods: We conducted a retrospective observational study at a tertiary care centre from June 2023 to June 2024, enrolling 107 adults diagnosed with dengue (NS1/IgM positive) or KFD (Polymerase chain reaction assay-confirmed). Clinical and biomarker data, including haematological, hepatic, renal, inflammatory, and endothelial parameters, were analysed to find differences between the two diseases and identify predictors of 28-day mortality. Results: Eleven patients (10.3%) died within 28 days. KFD patients were older and had higher adrenomedullin and transaminase levels. Dengue cases showed higher SOFA scores and more severe thrombocytopenia. Mortality was associated with elevated coagulation markers, serum creatinine, procalcitonin, and adrenomedullin. Aspartate aminotransferase was more frequently elevated in non-survivors. Conclusions: Combining conventional and novel biomarkers, such as adrenomedullin, may help early identification of high-risk patients, improving prognostication and management of endemic flaviviral infections.


  • Open Access

    Utility of core to peripheral temperature gradient using infrared thermography in the assessment of patients with sepsis and septic shock in the emergency medicine department

    by Vrinda Lath, Prithvishree Ravindra, Freston Marc Sirur, Rachana Bhat, Avinash Bhat, Karthik Naik, Ramya R, Jayaraj Mymbilly Balakrishnan

    Objective: Sepsis is a disease affecting microcirculation, reflected in temperature changes between the core and the skin. This study explores correlation of this gradient using infrared thermography (IRT) with mortality and markers of hypoperfusion in patients admitted with sepsis and septic shock and its changes with resuscitation. Design: We conducted a prospective, single center observational study on patients admitted in the Department of Emergency Medicine of a tertiary care center in Karnataka, India. These patients were enrolled based on the inclusion criteria and infrared thermography was performed and cases were followed up after 28 days. Adults presenting to the emergency medicine department with clinically suspected sepsis or septic shock were enrolled and infrared thermography was performed. A final sample size of 187 cases was analyzed after retrospectively excluding patients with any exclusion criteria. Interventions: Patients underwent thermal imaging of all four limbs on arrival and after 3 hours of resuscitation. Core temperature was measured using a tympanic thermometer. Infrared thermography was performed, and limb temperature was extracted from the images. Other parameters including mean arterial pressure and lactate were recorded and SOFA score was calculated. Outcome measure(s): The temperature gradients were correlated with 7 and 28-day mortality along with markers of hypoperfusion including mean arterial pressure and serum lactate levels. Results: A total of 187 patients were included, with a mean SOFA score of 5. Forty four patients (23.5%) died within 7-days. 28-day mortality was 31%. Temperature gradients of core to knee > 8.85°F (p = 0.003) and core to great toe > 12.25°F (p = 0.020) on arrival were found to be correlated with 7-day mortality. Core to knee temperature gradient was found to correlate with 48-hour mortality(p < 0.013). Core to index finger gradient on arrival correlated with vasopressor requirement within 48h (p = 0.020). Core to index finger temperature gradient had a negative correlation with mean arterial pressure (spearman coefficient − 0.286, p = < 0.001), and a positive correlation with lactate (0.281, p = < 0.001), SOFA score (0.242, p = 0.001), qSOFA score (0.167, p = 0.023). Conclusions: Core-to-knee and core-to-toe temperature gradients using IRT significantly correlate with 7-day mortality. IRT can be a useful adjunct to predict clinical courses in patients with sepsis and septic shock.


  • Utility of Adrenomedullin in Predicting Outcomes in Patients with Acute Febrile Illness in the Tropics: A Prospective Observational Study

    by Praveen Kumar Tirlangi, Prithvishree Ravindra, Rachana Bhat, Vijetha Shenoy Belle, Souvik Chaudhuri, Ashwitha Bhat, Poojashree Acharya, Nitin Gupta

    : Acute febrile illnesses (AFI) such as dengue, leptospirosis, and scrub typhus start with fever, but some patients can deteriorate rapidly. Identifying these patients at risk is necessary to ensure early referral. The study’s objective was to assess the utility of serum adrenomedullin (ADM) as a biomarker in predicting outcomes in adult AFI patients presenting to the emergency department (ED). In this prospective observational study, all consecutive patients admitted with AFI through the ED between June 2023 and February 2024 were assessed for eligibility. Clinical and laboratory findings were noted. The serum samples sent routinely for biochemical tests were used to calculate ADM levels at admission and 48 hours later (whenever possible). Clinically relevant outcome variables were collected for all patients. The utility of ADM in predicting 7-day mortality was evaluated for primary outcome analysis using a stepwise binary logistic regression. A total of 181 patients were recruited, with dengue (n = 91, 50%) being the most common diagnosis. The median sequential organ failure assessment score at admission was 5 (IQR: 3–10). The 7-day mortality was 26 (14%, 95% CI: 9.3–19.5). The median admission ADM levels and difference in ADM levels at 48 hours were significantly higher in those who died by day 7. Adrenomedullin levels at admission were found to be an independent predictor of 7-day mortality (adjusted odds ratio: 1.002, 95% CI: 1.001–1.004, P = 0.005). High ADM levels can be used for early referral in patients with tropical AFI. There is a need to explore the utility of antibodies targeting ADM in clinical studies.


  • Open Access

    Comparison between a low-cost model (CPR Pillow) and a mannequin in training hands only cardiopulmonary resuscitation (CPR): A randomised trial

    by Abhinav Nehra, Prithvishree Ravindra, Rachana Bhat, Savan Kumar Nagesh, Yash Alok, Nisarg S., Sagar Shanmukhappa Maddani, Jayaraj Mymbilly Balakrishnan


  • Open Access

    Portable Biosafety Barrier Innovations to Limit Transmissibility of Infectious Diseases during Patient Care in Resource-limited Settings during the COVID-19 Pandemic

    by Jayaraj Mymbilly Balakrishnan, Freston Marc Sirur, Nayan Prakash, Rachana Bhat, William Wilson, Bharath Angadi, Sanjan Asanar

    The coronavirus disease-2019 (COVID-19) pandemic has brought about a change in healthcare practices that are likely to persist into the foreseeable future. In particular, is the exposure risk to the healthcare practitioners in the emergency department (ED) and the intensive care units. Mitigating this issue in a low-resource setting remains challenging, and in particular, in developing nations such as India, where ED patient flows can overwhelm a system and its human resources, breaking down processes and infecting healthcare workers (HCWs). To tackle this and the possible lack of appropriate personal protective equipment (PPE), we designed and built biosafety barrier devices using local resources for use in patient stabilization, transport, and continued care in the ED or the intensive care units. Four biosafety devices bio-safe levels 1 and 2, ultra-ductile portable interface of interventions in infections, and tented transport trolley for transmissibility (4T) were tested for the feasibility of usage for patient care during the pandemic with simulation. We anticipate that with time it may be common practice for in situ isolation of patients in the emergency departments with a suspicion of an infectious disease. With the proof of concept, simulation, hospital infection control committee (HICC) approval, and trial run, we look to close the gaps that exist in these initial innovations. Balakrishnan JM, Sirur FM, Prakash N, Bhat R, Wilson W, Angadi B, et al. Portable Biosafety Barrier Innovations to Limit Transmissibility of Infectious Diseases during Patient Care in Resource-limited Settings during the COVID-19 Pandemic. Indian J Crit Care Med 2022;26(9):1036–1038.

  • Open Access

    Steroids use in non-oxygen requiring COVID-19 patients: a systematic review and meta-analysis

    by A K Sahu, R Mathew, R Bhat, C Malhotra, J Nayer, P Aggarwal, S Galwankar

    Corticosteroids have become the mainstay treatment in severe COVID-19. However, its role is mild disease is controversial due to lack of robust scientific evidence. This systematic review and meta-analysis were conducted to assess effect of steroids in mild COVID-19 patients. PubMed, EMBASE, Web of Science and medRxiv were searched from 31 December 2019 to 14 May 2021 for studies that reported effectiveness of steroids in non-oxygen requiring COVID-19 patients in terms of progressing to severe disease, mortality, duration of fever, duration of viral clearance and length of hospital stay (LOHS). Studies on inhalational steroids, case reports and reviews were excluded. Risk of bias (ROB) was assessed by the Cochrane’s ROB tool and ROBANS tool. Quantitative data synthesis was done using the generic inverse variance method. A total of 6411 studies were identified, 2990 articles were screened after exclusion. Seven studies which fit the criteria (involving 2214 non-oxygen requiring COVID-19 patients) were included and analysed. Overall odds of progression to severe disease among the non-oxygen requiring COVID-19 patients receiving steroids was 5.97 [95% confidence interval (CI): 1.27–27.99, I2 = 0%] and odds of death (OR: 1.35, 95% CI: 1.01–1.79; I2 = 0%) as compared to the patients not receiving steroids. Mean duration of fever (7.4 days), duration to viral clearance (18.9 days) and LOHS (20.8 days) were significantly higher in the steroid arm, as compared to that in no-steroid arm (6.7, 16.5 and 15.2 days, respectively). Steroids in non-oxygen requiring COVID-19 patients can be more detrimental than beneficial. The study was prospectively registered in PROSPERO (CRD 42021254951).